|
|
Sold Out
Book Categories |
| Introduction | 1 | |
| Genetic Susceptibility, Predicting Risk and Preventing Cancer | 7 | |
| Novel Approaches to Identify Low Penetrance Cancer Susceptibility Genes Using Mouse Models | 19 | |
| Development of Novel Selective Cell Ablation in the Mammary Gland and Brain to Study Cell-Cell Interactions and Chemoprevention | 31 | |
| Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs | 46 | |
| Preclinical Models for Chemoprevention of Colon Cancer | 58 | |
| New Cancer Biomarkers Deriving from the NCI Early Detection Research | 72 | |
| Tamoxifen's Impact as a Preventive Agent in Clinical Practice and an Update on the STAR Trial | 87 | |
| Aromatase Inhibitors in Prevention - Data from the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial and the Design of IBIS-II (The Second International Breast Cancer Intervention Study) | 96 | |
| HRT Opposed by Low Dose Tamoxifen (HOT Study). Rationale and Design | 104 | |
| Is Mammography Screening for Breast Cancer Really Not Justifiable? | 115 | |
| How Reliable is the Evidence for Screening Mammography? | 129 | |
| Political Interpretation of Scientific Evidence - Case Study of Breast Cancer Screening Policies Around the World | 140 | |
| Skin Cancer Chemoprevention: Strategies to Save our Skin | 151 | |
| Chemoprevention of Non-Melanoma Skin Cancer: Experience with a Polyphenol from Green Tea | 165 | |
| Chemoprevention of Lung Cancer: New Directions | 172 | |
| Key Issues in Lung Cancer Chemoprevention Trials of New Agents | 182 | |
| Prevention of Prostate Cancer | 199 | |
| Clinical Models for Testing Chemopreventative Agents in Prostate Cancer and Overview of SELECT: The Selenium and Vitamin E Cancer Prevention Trial | 212 | |
| Problems with Prostate Specific Antigen Screening: A Critical Review | 226 | |
| Genetic Predisposition as a Basis for Chemoprevention, Surgical and Other Interventions in Colorectal Cancer | 235 | |
| Fecal Occult Blood (FOB) Screening - Trial Evidence, Practice and Beyond | 248 | |
| Is FOB-Screening Really the Answer for Lowering Mortality in Colorectal Cancer? | 254 | |
| Summary and Conclusions | 264 |
| Price | Condition | Delivery | Seller | Action |
| $99.99 | Digital |
| WonderClub |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Tumor Prevention and Genetics
X
This Item is in Your Inventory
Tumor Prevention and Genetics
X
You must be logged in to review the productsX
X
X
Add Tumor Prevention and Genetics, This book presents a comprehensive update of the latest findings in oncogenetics. It also investigates the relevance of preclinical models with respect to clinical cancer prevention (primary and secondary) for major cancer types such as breast, skin, lung, Tumor Prevention and Genetics to the inventory that you are selling on WonderClubX
X
Add Tumor Prevention and Genetics, This book presents a comprehensive update of the latest findings in oncogenetics. It also investigates the relevance of preclinical models with respect to clinical cancer prevention (primary and secondary) for major cancer types such as breast, skin, lung, Tumor Prevention and Genetics to your collection on WonderClub |